Dafni deals with various areas of EU competition law, including merger control (M&A and joint ventures), cartel and antitrust investigations, horizontal and vertical agreements and compliance programmes. Dafni advises clients active in a broad range of industries including pharmaceuticals, consumer goods, financial services and energy. Dafni has particular expertise in the pharmaceutical sector, where she advises major international companies on patent settlements and licensing agreements, life-cycle management strategies and merger control issues.
435
This article has been nominated for the 2021 Antitrust Writing Awards. Click here to learn more about the Antitrust Writing Awards. On 30 January 2020 the European Court of Justice (“ECJ”) clarified for the first time the criteria governing whether so-called “pay-for-delay” agreements entered (...)
12
The EU Commission introduces an online tool for the submission of evidence in cartel and non-cartel cooperation proceedings
109
On 8 September 2016 the General Court (GC) handed down its judgments in relation to the appeals brought by Lundbeck and a number of generic companies (Sun Pharma (Ranbaxy), Arrow, Generics UK, Merck and Xellia/Alpharma) against a European Commission (Commission) decision finding that the (...)
19 avenue Jean Aicard
75011 Paris, France
106 West 32nd Street, Suite 149
New York, NY, 10001, USA
563 Chiswick High Road
W4 3AY London, UK
